+86 400-821-9890

About OrigiMed

OrigiMed is a medical science and technology transforming company which focuses on developing new technologies and clinical applications for all types of cancer patients. By carrying out more comprehensive and high-throughput methods, leveraging wholesome bioinformatics analysis and clinical annotation, we identify cancer specific molecular markers and genomic features to guide targeted or immuno-therapy, ultimately aim to fortify the evolution of cancer precision medicine in China.

Sequencing Center

OrigiMed has 4,000 m² (43,057 ft²) lab space which is built following international standards and 4,200 m² (45,209 ft²) office space.

Currently, there are one NovaSeq 6000, four NextSeq 500 and one MiniSeq in using.

Bioinformatics and Data Processing Center

Powerful computer, storage and database infrastructure were built in OrigiMed.
A large collection of bioinformatics software and public data warehouse are installed and maintained regularly.

• Storage capacity > 4PB
• CPU core number > 2,304 cores
• Total memory > 20.4Tb
• Total peak performance > 110 TeraFLOPS/s